EF
CVS icon

Empowered Funds’s CVS Health CVS Stock Holding History

Empowered Funds’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
120,742
-12,034
-9% -$1.07M 0.07% 334
2026
Q1 		$9.54M Buy
+132,776
New +$10.2M 0.06% 400
2025
Q4 		– Sell
-75,912
Closed -$5.72M – 1219
2025
Q3 		$5.72M Sell
75,912
-34,889
-31% -$2.39M 0.06% 439
2025
Q2 		$7.64M Sell
110,801
-100,683
-48% -$6.6M 0.09% 300
2025
Q1 		$14.3M Buy
211,484
+179,461
+560% +$10.7M 0.2% 88
2024
Q4 		$1.44M Sell
32,023
-177,659
-85% -$9.97M 0.02% 861
2024
Q3 		$13.2M Buy
209,682
+72,228
+53% +$4.21M 0.21% 90
2024
Q2 		$8.12M Buy
137,454
+2,108
+2% +$132K 0.14% 170
2024
Q1 		$10.8M Buy
135,346
+49,048
+57% +$3.75M 0.19% 105
2023
Q4 		$6.81M Buy
86,298
+20,277
+31% +$1.44M 0.17% 145
2023
Q3 		$4.61M Buy
66,021
+54,171
+457% +$3.84M 0.14% 196
2023
Q2 		$819K Buy
11,850
+5,802
+96% +$413K 0.03% 671
2023
Q1 		$449K Buy
6,048
+1,919
+46% +$161K 0.03% 409
2022
Q4 		$385K Buy
+4,129
New +$398K 0.03% 382
2021
Q3 		– Sell
-47,350
Closed -$3.95M – 221
2021
Q2 		$3.95M Buy
47,350
+7,293
+18% +$597K 0.5% 74
2021
Q1 		$2.74M Hold
40,057
– – 0.52% 55
2020
Q4 		$2.74M Sell
40,057
-7,697
-16% -$501K 0.52% 55
2020
Q3 		$2.79M Buy
+47,754
New +$2.97M 0.87% 36
2018
Q2 		– Sell
-48,167
Closed -$3.02M – 101
2018
Q1 		$3.02M Buy
48,167
+16,160
+50% +$1.16M 1.1% 34
2017
Q4 		$2.32M Buy
32,007
+9,658
+43% +$702K 1.16% 23
2017
Q3 		$1.82M Buy
22,349
+1,547
+7% +$122K 1.18% 31
2017
Q2 		$1.67M Buy
20,802
+1,455
+8% +$115K 1.36% 23
2017
Q1 		$1.52M Buy
+19,347
New +$1.54M 1.56% 31

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Empowered Funds's CVS Position: Q2 2026 in Review

Empowered Funds reduced its CVS Health (CVS) stake by 9.1% in Q2 2026, selling an estimated $1.07M and leaving 120,742 shares worth $12.5M. The position accounts for 0.07% of the portfolio, ranked #334.

Empowered Funds first reported a position in CVS in Q1 2017 and has held it in 23 quarters since. The position peaked at $14.3M in Q1 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Empowered Funds held 120,742 shares of CVS Health worth $12.5M as of Q2 2026.
  • Empowered Funds sold 12,034 CVS Health shares in Q2 2026, an estimated $1.07M.
  • CVS Health made up 0.07% of Empowered Funds's portfolio in Q2 2026, its #334 holding.
  • Empowered Funds first reported a position in CVS Health in Q1 2017 and has held it in 23 quarters since.
  • Empowered Funds's CVS Health position peaked at $14.3M in Q1 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.